Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 5.2 CHF 1.96% Market Closed
Market Cap: 191.6m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Molecular Partners AG
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Molecular Partners AG
PP&E Net Peer Comparison

Comparables:
ADCT
ACIU
CRSP
BSLN
KURN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Molecular Partners AG
SIX:MOLN
PP&E Net
CHf4.9m
CAGR 3-Years
-17%
CAGR 5-Years
1%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
PP&E Net
$16.1m
CAGR 3-Years
50%
CAGR 5-Years
61%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
PP&E Net
CHf6.2m
CAGR 3-Years
-8%
CAGR 5-Years
2%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
PP&E Net
$284.8m
CAGR 3-Years
0%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
PP&E Net
CHf19.4m
CAGR 3-Years
73%
CAGR 5-Years
28%
CAGR 10-Years
4%
Kuros Biosciences AG
SIX:KURN
PP&E Net
CHf2.9m
CAGR 3-Years
3%
CAGR 5-Years
-1%
CAGR 10-Years
N/A

See Also

What is Molecular Partners AG's PP&E Net?
PP&E Net
4.9m CHF

Based on the financial report for Jun 30, 2024, Molecular Partners AG's PP&E Net amounts to 4.9m CHF.

What is Molecular Partners AG's PP&E Net growth rate?
PP&E Net CAGR 5Y
1%

Over the last year, the PP&E Net growth was -23%. The average annual PP&E Net growth rates for Molecular Partners AG have been -17% over the past three years , 1% over the past five years .

Back to Top